Support for clinical core processes

The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Urwanisch, L., Unger, M. S., Sieberer, H., Dang, H-H., Neuper, T., Regl, C., Vetter, J., Schaller, S., Winkler, S., Kerschbamer, E., Weichenberger, C., Krenn, P., Luciano, M., Pleyer, L., Greil, R., Huber, C., Aberger, F. & Horejs-Hoeck, J., 7 Feb 2023, In: Cancers. 15, 4, 1039.
Research output: Contribution to journal › Article › peer-review

Open Access
Using Explainable Artificial Intelligence for Data Based Detection of Complications in Records of Patient Treatments
Strobl, M. T., Vetter, J., Halmerbauer, G., Königswieser, T. & Winkler, S., 10 Feb 2023, Computer Aided Systems Theory–EUROCAST 2022: 18th International Conference, Las Palmas de Gran Canaria, Spain, February 20–25, 2022, Revised Selected Papers. Springer, p. 173-180 8 p.
Research output: Chapter in Book/Report/Conference proceedings › Conference contribution › peer-review
FHIR2BPMN: Delivering Actionable Knowledge by Transforming Between Clinical Pathways and Executable Models
Helm, E., Pointner, A., Krauss, O., Schuler, A., Traxler, B., Arthofer, K. & Halmerbauer, G., 16 May 2022, In: Studies in Health Technology and Informatics. 292, p. 9-14 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access

Fingerprint